The Mountain View, California-based company—which creates personalized models of the heart from CT scans—is taking rival Cleerly to court. 

The system was cleared by the U.S. Food and Drug Administration in September and was adopted by the interventional team at Atlanta-based Emory shortly after.

Women who underwent mammograms at the facility during the specified timeframe may need to have those exams repeated. 

The joint venture is intended to advance cancer diagnostics and treatment, with the potential to rake in over $4 billion, those involved estimate.  

CHAMPIONSGATE, Fla. — Moffatt, currently president of radiology AI and coding firm Reasint, is the 2026 winner of the prestigious Calhoun Award. 

CHAMPIONSGATE, Fla. — Kaihan Krippendorff, MBA, spoke on April 12 during the opening keynote of the Radiology Business Management Association’s annual meeting.